Search

Your search keyword '"Viallard, Jean-Francois"' showing total 231 results

Search Constraints

Start Over You searched for: Author "Viallard, Jean-Francois" Remove constraint Author: "Viallard, Jean-Francois"
231 results on '"Viallard, Jean-Francois"'

Search Results

1. Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants

2. Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes

3. Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial

4. Pregnancy in primary immunodeficiency diseases: The PREPI study

6. The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease

7. Early-onset autoimmunity associated with SOCS1 haploinsufficiency.

8. Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

9. Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity

10. Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study

11. Intravenous Immunoglobulins Tapering and Withdrawal in Systemic Capillary Leak Syndrome (Clarkson Disease)

12. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

13. Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice

14. A French cohort for assessing COVID-19 vaccine responses in specific populations

15. “Idiopathic Eosinophilic Vasculitis”: Another Side of Hypereosinophilic Syndrome? A Comprehensive Analysis of 117 Cases in Asthma-Free Patients

17. One-month humoral response following two or three doses of messenger RNA coronavirus disease 2019 vaccines as primary vaccination in specific populations in France: first results from the Agence Nationale Recherche contre le Sida (ANRS)0001S COV-POPART cohort

18. The CARMEN-France registry of adult patients with immune thrombocytopenia and autoimmune hemolytic anemia in France

20. Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial

21. Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants

22. P1613: REAL-WORLD USE OF FOSTAMATINIB IN FRANCE. INTERIM RESULTS OF A NATIONAL REGISTRY.

23. Efficacy and safety of two rituximab biosimilars for treating immune thrombocytopenia: a reference-product matched study

24. Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia

26. Multirefractory Primary Immune Thrombocytopenia in Adults: Prevalence and Burden. Results from the Carmen-France Registry

27. Platelet Count Threshold Associated with Bleeding in Adult Patients with Immune Thrombocytopenia Treated with Antiplatelet Drugs. Results from the Carmen-France Registry

28. One-month humoral response following two or three doses of mRNA Covid-19 vaccines as primary vaccination in specific populations in France: first results from the ANRS0001S COV-POPART cohort

29. Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients

30. ELANE neutropenia and solid tumors: Four cases from the French severe chronic neutropenia registry

32. A case-control study to assess the risk of immune thrombocytopenia associated with vaccines

33. The consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (Clarkson disease)

35. Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome

36. Late-Onset Combined Immune Deficiency: A Subset of Common Variable Immunodeficiency with Severe T Cell Defect

37. Infections in 252 Patients with Common Variable Immunodeficiency

38. Presentation and Real-World Management of Giant Cell Arteritis (Artemis Study)

39. Splenectomy for Primary Immune Thrombocytopenia Revisited at the Era of Thrombopoietin Receptor Agonists: New Insights for an Old Treatment

44. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

46. Autoimmune Disorders and Quadrivalent Human Papillomavirus Vaccination of Young Females: 415.

47. Prevention of infection in asplenic adult patients by general practitioners in France between 2013 and 2016

48. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort

Catalog

Books, media, physical & digital resources